Toggle navigation
Home
Search
Services
Blog
Contact
About
Isolation of Stage-Specific Markers in Cartilage Tumors
Persinger, Sharon M.
University of Texas MD Anderson Cancer Center, Houston, TX, United States
Search grants from Sharon Persinger
Search grants from University of Texas MD Anderson Cancer Center
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Apoe based solid nanoparticles for prevention and treatment of Alzheimer's Disease
Protein-Dopamine Adducts in Methamphetamine Toxicity
Minority Predoctoral Fellowship Program
Creighton University Health Careers Opportunity Program
Minority High School Student Research Apprentice Program
Recently added grants:
Cancer Epidemiology Research Program
Community Outreach and Engagement
Developmental Funds
Planning and Evaluation
Clinical Protocoal and Data Management
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
1F32CA009368-01
Application #
3034811
Study Section
Biological Sciences 2 (BIOL)
Project Start
1993-02-01
Project End
Budget Start
1992-09-01
Budget End
1993-08-31
Support Year
1
Fiscal Year
1992
Total Cost
Indirect Cost
Institution
Name
University of Texas MD Anderson Cancer Center
Department
Type
Other Domestic Higher Education
DUNS #
001910777
City
Houston
State
TX
Country
United States
Zip Code
77030
Related projects
NIH 1993
F32 CA
Isolation of Stage-Specific Markers in Cartilage Tumors
Persinger, Sharon M. / University of Texas MD Anderson Cancer Center
NIH 1992
F32 CA
Isolation of Stage-Specific Markers in Cartilage Tumors
Persinger, Sharon M. / University of Texas MD Anderson Cancer Center
Publications
Yokoyama, Satoru; Woods, Susan L; Boyle, Glen M et al.
(2011)
A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma.
Nature 480:99-103
Comments
Be the first to comment on Sharon Persinger's grant